ECOR

ElectroCore

Stock NASDAQ – Stock Market Prices, News & Analysis

ElectroCore is a medical technology company specializing in the development of non-invasive treatments based on vagus nerve stimulation for neurological conditions, including headaches and migraines.

$ 6.73
0.52 %

ElectroCore

$ 6.73
0.52 %
ECOR

ElectroCore is a medical technology company specializing in the development of non-invasive treatments based on vagus nerve stimulation for neurological conditions, including headaches and migraines.

Price history of ElectroCore
Price history of ElectroCore

Performance & Momentum

6 Months 34.06 %
1 Year 12.54 %
3 Years 2.60 %
5 Years 74.93 %

Strategic Analysis

ElectroCore • 2026

ElectroCore develops innovative medical devices based on non-invasive vagus nerve stimulation, targeting neurological conditions such as migraines. Its unique technological positioning in a niche segment offers differentiating potential versus conventional treatments.

Strengths
  • Differentiated non-invasive technology with strong therapeutic potential
  • Focus on the neurology market with significant unmet clinical needs
  • Track record of strong long-term growth despite volatile market cycles
Weaknesses
  • Exposure to high share-price volatility tied to commercial and regulatory results
  • Mixed recent performance with a significant decline over a longer horizon
Momentum

Current moderate momentum reflects a period of balance between turnaround expectations and market uncertainty. Past volatility calls for heightened caution, and a strong catalyst would be needed to reignite the upward trend.

Similar stocks to ElectroCore

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone